Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants

Trump administration pulls 750,000 people from ACA coverage, claiming fraud

The Trump administration has announced the removal of 750,000 people from coverage on the Affordable Care Act marketplace. Vice President JD Vance asserted that these individuals are suspected of “fraudulently enrolling in the program.”

HHS issues direct final rule to reduce reliance on animal testing

FDA has issued a direct final rule that changes the language in its regulations so that “animal testing” is no longer described as the default or defining form of “nonclinical” safety testing.

September 25, 2026

Vol.52 No.35

By Claire Marie Porter

In Brief

UCLA researchers receive $7M NIH grant to launch trial for immunotherapy-related diabetes

UCLA researchers have received a grant worth up to $7 million over five years from the National Institute of Allergy and Infectious Diseases to launch a first-in-human clinical trial evaluating whether drugs already used to treat autoimmune diseases can prevent or reverse immune checkpoint inhibitor-induced type 1 diabetes, a rare but often permanent complication of cancer immunotherapy.

September 18, 2026

Vol.52 No.34

In Brief

VCU Massey researchers receive $2.5M NIH grant for targeted therapy for breast, pancreatic cancer

Researchers at VCU Massey Comprehensive Cancer Center were recently awarded a $2.5 million R01 grant from NCI. The five-year grant will allow Massey to evaluate the efficacy of TROP2 targeted antibody-drug conjugates to further enhance therapeutic benefits in both breast and pancreatic cancer care.

September 18, 2026

Vol.52 No.34

Cancer Policy

Trump’s vaccine executive order draws criticism from medical community, may put cancer populations at risk

President Trump earlier this week issued an executive order that would drastically change the childhood immunization schedule—limiting recommendations, spacing out shots, and splitting the combined measles, mumps, and rubella vaccine into single-disease injections.

August 14, 2026

Vol.52 No.32

By Claire Marie Porter

Cancer Policy

HRSA redrafts 340B rebate pilot program after courts block the original version

After returning to the drawing board, the Health Resources and Services Administration has announced a second iteration of the 340B Rebate Model Pilot Program, after it withdrew the original pilot earlier this year.

August 07, 2026

Vol.52 No.31

By Sara Willa Ernst

Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants

YOU MAY BE INTERESTED IN

Trump administration pulls 750,000 people from ACA coverage, claiming fraud

HHS issues direct final rule to reduce reliance on animal testing

UCLA researchers receive $7M NIH grant to launch trial for immunotherapy-related diabetes

VCU Massey researchers receive $2.5M NIH grant for targeted therapy for breast, pancreatic cancer

Trump’s vaccine executive order draws criticism from medical community, may put cancer populations at risk

HRSA redrafts 340B rebate pilot program after courts block the original version

Renew today!

Subscriber content

Never miss an issue!

Login